GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
Z51.12
Encounter for antineoplastic immunotherapy
ICD10CM code
Medical Policies and Guidelines for Encounter for antineoplastic immunotherapy
Related policies from health plans
ANTHEM-BLUECROSS-CA
Abecma (idecabtagene vicleucel)
ANTHEM-BLUECROSS-CA
Abecma (idecabtagene vicleucel)
ANTHEM-BLUECROSS-CA
Breyanzi (lisocabtagene maraleucel)
ANTHEM-BLUECROSS-CA
Breyanzi (lisocabtagene maraleucel)
ANTHEM-BLUECROSS-CA
Kymriah (tisagenlecleucel)
ANTHEM-BLUECROSS-CA
Provenge (sipuleucel-T)
ANTHEM-BLUECROSS-CA
Yescarta (axicabtagene ciloleucel)
CIGNA
Transthoracic Echocardiography in Adults - (0510)
CIGNA
Transthoracic Echocardiography in Adults - (0510)
CIGNA
Transthoracic Echocardiography in Children - (0523)
CIGNA
Transthoracic Echocardiography in Children - (0523)
Similar Codes
ICD10CM codes
Z51.12
- Encounter for antineoplastic immunotherapy
Z51.1
- Encounter for antineoplastic chemotherapy and immunotherapy
Z51.0
- Encounter for antineoplastic radiation therapy
Z51.11
- Encounter for antineoplastic chemotherapy
Z29.1
- Encounter for prophylactic immunotherapy
Z92.21
- Personal history of antineoplastic chemotherapy
T45.1X5A
- Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
T45.1X5D
- Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter
T45.1X5
- Adverse effect of antineoplastic and immunosuppressive drugs
T45.1X1A
- Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encount
HCPCS codes
J9999
- Not otherwise classified, antineoplastic drugs
S9359
- Home infusion therapy, anti-tumor necrosis factor intravenous therapy; (e.g., infliximab); administr
J9055
- Injection, cetuximab, 10 mg
J9227
- Injection, isatuximab-irfc, 10 mg
J9312
- Injection, rituximab, 10 mg
J7599
- Immunosuppressive drug, not otherwise classified
J9311
- Injection, rituximab 10 mg and hyaluronidase
J9351
- Injection, topotecan, 0.1 mg
J9022
- Injection, atezolizumab, 10 mg
Q5102
- Injection, infliximab, biosimilar, 10 mg
CPT4 codes
96402
- Chemotherapy administration, subcutaneous or intramuscular; hormonal anti-neoplastic
96401
- Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic
96406
- Chemotherapy administration; intralesional, more than 7 lesions
96405
- Chemotherapy administration; intralesional, up to and including 7 lesions
96549
- Unlisted chemotherapy procedure
80230
- Infliximab
86849
- Unlisted immunology procedure
38242
- Allogeneic lymphocyte infusions
96411
- Chemotherapy administration; intravenous, push technique, each additional substance/drug (List separ
01922
- Anesthesia for non-invasive imaging or radiation therapy